Orphan Status Granted to Novo’s Concizumab, Eisai’s E7090 and More

February 24, 2021
The Ministry of Health, Labor and Welfare (MHLW) on February 19 granted orphan drug designation to a batch of medicines including Novo Nordisk Pharma’s hemophilia A/B treatment concizumab and Eisai’s biliary tract cancer med E7090. Concizumab was granted the orphan...read more